版本:
中国

BRIEF-China Biologic receives CFDA clinical trial approval for Human Coagulation Factor IX

Sept 19 China Biologic Products Inc :

* China Biologic receives CFDA clinical trial approval for Human Coagulation Factor IX

* China Biologic plans to commence clinical trials for FIX product in 2017 and expects to complete these trials by 2018. Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐